Potassium
SupplementThe medical score is higher, as robust meta-analyses demonstrate a clearly established effect on blood pressure and stroke risk [s1, s2, s3]. The community rates potassium more cautiously, as many users employ it primarily for muscle cramps and energy, where the evidence is weaker, and safety concerns temper enthusiasm [c1, c3].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Potassium is among the best-supported supplements in existence: over 32 RCTs and Cochrane-level meta-analyses consistently confirm blood pressure reduction in hypertensives, and the WHO recommends it for stroke prevention. Community reports on muscle cramps and energy are widespread, though clinical evidence for these uses is thinner. The main concern isn't efficacy — it's safety: hyperkalemia can trigger serious cardiac arrhythmias, making high-dose supplementation without blood monitoring genuinely risky. Healthy adults sticking to physiological doses (≤2,000 mg/day) are on solid ground; self-experimenting with high doses is not.
Description
Essential mineral for blood pressure regulation, nerve and muscle function; well-documented blood pressure-lowering effect at elevated baseline values [s1, s2].
Potassium is the most important intracellular cation in the human body and plays a central role in maintaining membrane potential, signal conduction in nerves and muscles, and cardiac function [s6]. Approximately 98% of total body potassium is located intracellularly; extracellular potassium primarily regulates the excitability of cell membranes [s6]. The daily intake recommendation for adults according to the DGE is 4,000 mg/day; pregnant women also require 4,000 mg/day, and breastfeeding women 4,400 mg/day [s7]. Potassium is primarily obtained through potassium-rich foods such as bananas, spinach, legumes, and potatoes. Supplementation in the form of potassium citrate, potassium chloride, or potassium gluconate is appropriate when dietary intake is insufficient or demand is increased (e.g., in athletes with heavy sweating, diuretic therapy, low-sodium diets) [s6, s7]. Multiple meta-analyses of RCTs demonstrate that oral potassium supplementation significantly reduces systolic and diastolic blood pressure in hypertensive individuals [s1, s2, s3]. The FDA has published an authorized health claim stating that a diet high in potassium and low in sodium may reduce the risk of hypertension and stroke [s6]. In individuals with normal renal function, excess potassium is efficiently excreted renally; a risk of hyperkalemia from dietary potassium has not been established in those with healthy kidneys [s6]. Different potassium compounds vary in their applications: potassium citrate is preferentially used for kidney stone prevention and is considered particularly bioavailable; potassium chloride is the most common supplementation form; potassium gluconate is also well bioavailable and mildly tolerated [s4, s5].
Legal Status (DE)
In Germany, potassium is available over the counter as a dietary supplement (NEM). The BfR has developed maximum quantity proposals for potassium in dietary supplements; specific restrictions may apply depending on the food category [s9, s10]. Potassium chloride as a medicinal product in high doses (e.g., infusion solutions) is prescription-only. EU-wide, EFSA-approved health claims for the maintenance of normal blood pressure are authorized for potassium [s8].
Mechanism of Action
Potassium regulates the electrochemical membrane potential in virtually all cells of the body. The Na⁺/K⁺-ATPase pump actively transports 3 sodium ions out of the cell and 2 potassium ions in, maintaining a concentration gradient essential for action potentials in neurons and cardiomyocytes [s6]. Potassium contributes to blood pressure reduction via several mechanisms [s3, s6]: 1. Natriuresis: Increased potassium intake promotes renal sodium excretion, leading to a reduction in plasma volume and thereby blood pressure. 2. Vasodilation: Potassium activates Na⁺/K⁺-ATPase in vascular smooth muscle cells, causing their hyperpolarization and relaxation. 3. Baroreceptor sensitivity: Potassium can modulate the sensitivity of baroreceptors and receptors influencing vascular tone and the sympathetic nervous system [s3]. 4. Reduction of free radicals and improvement of endothelial function have been discussed as additional mechanisms in stroke prevention [s6]. In muscle tissue, potassium is responsible for repolarization following contraction; deficiency leads to muscle cramps, weakness, and arrhythmias. In cardiac muscle, potassium influences the duration of the action potential and the refractory period; both hypo- and hyperkalemia can trigger life-threatening arrhythmias [s11, s12].
Dosing
Allgemeine Supplementation / Mangelprävention
- Dose
- 1,000–2,000 mg potassium per day (as citrate or chloride)
- Frequency
- aufgeteilt auf 2–3 Dosen täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- With meals
- With food
- empfohlen
Blutdrucksenkung (adjuvant)
- Dose
- 2,000–3,500 mg potassium daily from food and/or supplements
- Frequency
- verteilt über den Tag
- Route
- oral
- Duration
- mindestens 4 Wochen
- Timing
- With meals
- With food
- empfohlen
Muskelkrämpfe / Sportler
- Dose
- 200–400 mg potassium citrate per single dose
- Frequency
- bei Bedarf, max. 2× täglich
- Route
- oral
- Duration
- situativ
- Timing
- Before or after physical exercise
- With food
- empfohlen
Nierensteinen vorbeugen (Kaliumcitrat)
- Dose
- as prescribed by physician, typically 1,500–3,000 mg/day potassium citrate
- Frequency
- 3× täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- With or after meals
- With food
- empfohlen
The BfR has developed maximum quantity proposals for potassium in dietary supplements; in the EU, a maximum of 200–300 mg potassium per daily dose is typically recommended for dietary supplements [s9, s10]. Total daily intake (diet + supplements) should not significantly exceed 4,000 mg/day in adults; considerably lower limits must be observed in cases of renal insufficiency [s6, s7]. No formal UL (Tolerable Upper Intake Level) has been set by NASEM for healthy adults, as the kidneys excrete excess potassium [s6].
Potassium supplements should always be taken with meals to minimize gastrointestinal irritation. High-dose potassium supplementation (>3,500 mg/day from dietary supplements) should only be undertaken under medical supervision with regular monitoring of serum potassium levels [s6, s11].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Gastrointestinale Beschwerden (Übelkeit, Erbrechen, Magenschmerzen, Durchfall) With oral intake, particularly on an empty stomach or at high single doses. Taking with meals reduces this risk [s6]. | häufig | leicht |
| Hyperkaliämie (erhöhtes Serumkalium >5,0 mmol/l) Rare in individuals with healthy kidneys, as the kidneys excrete excess potassium. Risk increases substantially with renal insufficiency, use of ACE inhibitors, potassium-sparing diuretics, or other factors that inhibit potassium excretion [s11, s12, s14]. | selten | schwer |
| Herzrhythmusstörungen (Arrhythmien) bei Hyperkaliämie Severe hyperkalemia can cause life-threatening arrhythmias and cardiac arrest. Hypokalemia (due to insufficient intake) also predisposes to arrhythmias [s11, s12]. | selten | schwer |
| Muskelschwäche und Lähmungserscheinungen bei Hyperkaliämie Hyperkalemia can cause generalized muscle weakness and, in severe cases, paralysis [s11]. | selten | moderat |
| Periphere Neuropathie bei chronischer Hyperkaliämie Chronic hyperkalemia has been associated with peripheral neuropathy; the mechanism is not fully elucidated [s12]. | theoretisch | moderat |
Contraindications
In severe renal insufficiency, the kidneys are unable to excrete excess potassium; life-threatening hyperkalemia with cardiac arrhythmias is possible. Potassium supplementation only under strict medical supervision with close monitoring [s11, s12].
Any additional potassium intake is contraindicated; immediate treatment of hyperkalemia is required [s11].
Aldosterone deficiency leads to reduced renal potassium excretion; risk of hyperkalemia is increased [s11].
Combination of potassium supplements with potassium-sparing diuretics significantly increases the risk of hyperkalemia; regular blood potassium monitoring is required [s14, s15].
ACE inhibitors reduce aldosterone and cause potassium retention; additional potassium supplementation increases the risk of hyperkalemia, particularly in impaired renal function [s14, s15].
Interactions
Synergistic
Potassium and calcium act together in regulating muscle and nerve function. Adequate potassium intake can reduce renal calcium excretion, thereby supporting bone density.
Magnesium and potassium act synergistically in regulating muscle, nerve, and cardiac function. Magnesium deficiency can impair cellular potassium uptake, making co-supplementation of both minerals advisable.
Magnesium glycinate and potassium jointly support electrolyte balance and may reduce fatigue and muscle cramps. Combined intake is particularly beneficial during athletic activity.
The combination of magnesium malate and potassium promotes neuromuscular function and electrolyte balance, particularly during intense exercise.
Magnesium threonate and potassium act together in regulating action potentials in nerve and muscle cells. Deficiency in either mineral can exacerbate deficits of the other.
Caution
Creatine may theoretically affect potassium homeostasis via water retention in muscle cells and altered renal function; caution is warranted in patients with impaired renal function or pre-existing electrolyte disorders, as hyperkalemia could be promoted.
Long-term berberine use has been discussed as potentially influencing potassium levels. Individuals with pre-existing electrolyte imbalances should have the combination monitored by a physician.
Studies
Tier A — High Evidence
Outcome: Reduction of systolic and diastolic blood pressure in hypertensive patients
Effect Size: Significant BP reduction; mean SBP reduction -4.48 mmHg (95% CI -6.59 to -2.37)
Outcome: Dose-response relationship between potassium intake and blood pressure reduction
Effect Size: Clear dose-response relationship at elevated blood pressure; smaller effects in normotensive individuals
Outcome: Blood pressure reduction in essential hypertension via oral potassium supplementation
Effect Size: Significant SBP and DBP reduction in the hypertension group
Tier B — Moderate Evidence
Outcome: Blood pressure reduction through DASH diet (high potassium + low sodium)
Effect Size: SBP reduction -5.5 mmHg vs. control diet
Outcome: Stroke reduction through increased potassium intake in hypertensive patients
Effect Size: Up to 24% reduction in stroke risk with higher potassium intake
Tier C — Low Evidence
Outcome: Bioavailability of various potassium compounds
Effect Size: No significant differences in bioavailability between citrate and gluconate
Community Evidence
Top reported benefits
- Reduction of muscle cramps (particularly calf cramps)
- Increased energy and reduced muscle fatigue
- Normalization of heart rhythm in perceived palpitations
- Improvement of overall electrolyte balance (e.g., after sweating)
Top reported issues
- Gastrointestinal complaints at high single doses or intake on an empty stomach
- No noticeable effect in some users without documented deficiency
- Uncertainty about safe dosing without blood testing
Experienced biohackers in r/Nootropics explicitly warn against unmonitored potassium supplementation without regular blood level testing [c3]. Potassium is classified as an "underestimated but also dangerous supplement." Several users report having begun supplementation on the advice of physicians or following electrolyte panels. The restriction of OTC preparations to ≤99 mg per capsule in the US is discussed and welcomed as a safety feature by parts of the community [c1, c3].
Scientific Sources
- The effect of potassium supplementation on blood pressure in hypertensive subjects: A systematic review and meta-analysis
Filippini T, Violi F, D'Amico R, et al. (2017). International Journal of CardiologyAPMID:28024910DOI - Aktualisierte Höchstmengenvorschläge für Vitamine und Mineralstoffe in Nahrungsergänzungsmitteln und angereicherten Lebensmitteln – Stellungnahme 006/2024
Bundesinstitut für Risikobewertung (BfR) (2024). BfRALink - Hyperkalemia – StatPearls
Simon LV, Hashmi MF, Farrell MW (2023). StatPearls / NCBI BookshelfBLink - Hyperkalemia: pathophysiology, risk factors and consequences
Kovesdy CP, Matsushita K, Sang Y, et al. (2019). Nephrology Dialysis TransplantationBLink - WHO-Empfehlung zur Schlaganfallprävention mit Hilfe von Kalium – Assmann-Stiftung für Prävention
Aburto NJ, et al. (WHO) (2013). WHO / Assmann-Stiftung für PräventionALink - Interaktionen: Kaliumsparende Diuretika und ACE-Hemmer
Pharmazeutische Zeitung Redaktion (2008). Pharmazeutische ZeitungBLink - Interaktionen: Kaliumsparende Diuretika und ACE-Hemmer – PTA-Forum
PTA-Forum Redaktion (2009). PTA-ForumBLink - Blood pressure interactions with the DASH dietary pattern, sodium, and potassium: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP)
Stamler J, Chan Q, Daviglus ML, et al. (2022). Journal of Nutrition / ScienceDirectBDOI - Effects of Diet and Sodium Reduction on Cardiac Injury, Strain, and Inflammation: The DASH-Sodium Trial
Juraschek SP, Mukamal KJ, Selvin E, et al. (2021). Journal of the American College of Cardiology (JACC)ADOI - Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses
Aburto NJ, Hanson S, Gutierrez H, Hooper L, Elliott P, Cappuccio FP (2013). BMJAPMID:23558164DOI - Hyperkalemia Associated with Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blockers in Chronic Kidney Disease
Luo J, Brunelli SM, Jensen DE, Yang A (2020). Cardiology and TherapyAPMID:32291375 - Effect of changes in potassium intake on blood pressure: a dose-response meta-analysis of randomized clinical trials (2000–2024)
Filippini T, et al. (2025). Clinical Kidney Journal (Oxford Academic)ADOI - Bioavailability of Magnesium and Potassium Salts Used as Potential Substitutes for Sodium Chloride in Human Nutrition — A Review
Merschmann LTB et al. (2025). Molecular Nutrition & Food ResearchADOI - Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials
Aburto NJ, Hanson S, Gutierrez H, et al. (2017). PLoS ONEADOI - Potassium Gluconate vs Potassium Citrate: A Complete Guide for Nutrition and Wellness
Elchemy Editorial Team (2024). Elchemy BlogCLink - Potassium Chloride vs. Potassium Citrate: Which Is Better?
GoodRx Editorial Team (2023). GoodRx HealthCLink - Potassium – Health Professional Fact Sheet
National Institutes of Health (NIH), Office of Dietary Supplements (2023). NIH Office of Dietary SupplementsALink - Revised Reference Values for Potassium Intake
Deutsche Gesellschaft für Ernährung (DGE), et al. (2017). PMC / Annals of Nutrition and MetabolismALink - EU Register on nutrition and health claims – Potassium
European Commission, EFSA (2012). Official Journal of the European UnionALink - Höchstmengenvorschläge für Kalium in Lebensmitteln inklusive Nahrungsergänzungsmitteln
Bundesinstitut für Risikobewertung (BfR) (2021). BfRALink
Community Sources
Storage
Unopened
Store in a dry place at room temperature (15–25 °C), protected from direct sunlight and moisture.
Opened
Keep container tightly closed; protect powder forms especially from moisture, as they are hygroscopic.
Notes
Potassium citrate powder is hygroscopic and may clump; use original packaging and do not remove silica gel packets.